UBS O'Connor’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-39,800
Closed -$106K – 719
2022
Q4
$106K Sell
39,800
-10,200
-20% -$471K ﹤0.01% 665
2022
Q3
$252K Sell
50,000
-63,100
-56% -$3.74M ﹤0.01% 836
2022
Q2
$931K Buy
113,100
+11,200
+11% +$779K 0.01% 777
2022
Q1
$107K Buy
101,900
+13,100
+15% +$1.08M ﹤0.01% 808
2021
Q4
$253K Buy
+88,800
New +$6.49M ﹤0.01% 718

Other funds holding THC

UBS O'Connor's THC Position: Q1 2023 in Review

UBS O'Connor sold out of Tenet Healthcare (THC) in Q1 2023, closing a stake of 34,626 shares — an estimated $1.69M sold.

UBS O'Connor first reported a position in THC in Q1 2017 and held it in 6 quarters. The position peaked at $7.89M in Q2 2017. 365 funds tracked by Wall St. Rank hold THC as of Q1 2023.

  • UBS O'Connor reported no remaining Tenet Healthcare position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 34,626 Tenet Healthcare shares in Q1 2023, an estimated $1.69M.
  • UBS O'Connor first reported a position in Tenet Healthcare in Q1 2017 and held it in 6 quarters.
  • UBS O'Connor's Tenet Healthcare position peaked at $7.89M in Q2 2017.
  • 365 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.